Entry Detail



General Information

Database ID:exR0369120
RNA Name:RPS16
RNA Type:mRNA
Chromosome:chr19
Starnd:-
Coordinate:
Start Site(bp):39433137End Site(bp):39435949
External Links:ENSG00000105193



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AL928654.3
chr14
105487199
105492267
+
ACTA2
chr10
88935074
88991339
-
ACOT9
chrX
23701055
23766475
-
AC009690.1
chr15
72284727
72375981
-
ACTN4
chr19
38647649
38731589
+
ALDOA
chr16
30064164
30070457
+
ADORA2A
chr22
24417879
24442357
+
ACTL6A
chr3
179562886
179588407
+
AKAP5
chr14
64465499
64474503
+
ADGRG6
chr6
142301854
142446266
+
AC010422.3
chr19
12643831
12648397
-
AICDA
chr12
8602170
8612867
-
AHSA1
chr14
77457870
77469472
+
AL121845.2
chr20
63738270
63740398
+
ACIN1
chr14
23058564
23095614
-
AL121845.3
chr20
63708864
63739103
+
ABCB8
chr7
151028422
151047782
+
ADM
chr11
10305073
10307397
+
ADIPOR2
chr12
1688574
1788674
+
ACO2
chr22
41469117
41528989
+
AEN
chr15
88621337
88632281
+
ACAA2
chr18
49782164
49813953
-
AC010323.1
chr19
8308283
8321379
-
AHCY
chr20
34280268
34311802
-
ADI1
chr2
3497366
3519531
-
AC004922.1
chr7
99325879
99394653
+
ADD1
chr4
2843857
2930076
+
ABCF1
chr6
30571393
30597179
+
AC124312.1
chr15
24955034
25000276
+
AK2
chr1
33007940
33080996
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-492
chr12
94834427
94834449
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC023509.1
chr12
53441741
53467528
+
AC027020.2
chr15
100547765
100550153
-
AC067852.1
chr17
42536510
42562062
+
AC096536.3
chr1
54874672
54883664
+
AC104596.1
chr4
142933195
143184861
-
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
AL132780.1
chr14
22929607
22956374
+
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.